No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ATAI Life Sciences Price Target Maintained With a $11.00/Share by Canaccord Genuity
ATAI Life Sciences Is Maintained at Buy by Canaccord Genuity
ATAI Life Sciences Analyst Ratings
Maxim Group Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $6
Express News | U.S.-Listed Shares of ATAI Life Sciences up 9.1%
RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up
Unlock the Full List